XENT - Intersect ENT - Stock Forecast

Health Care Equipment & Supplies - Industry

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $0.79. This is a potential upside of $0.79 (0%) from yesterday's end of day stock price of $0.

Intersect ENT's activity chart (see below) currently has 67 price targets and 52 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 74.26% with an average time for these price targets to be met of 106.43 days.

Most recent stock forecast was given by RICHARD NEWITTER from TRUIST on 11-Aug-2021. First documented stock forecast 16-Mar-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$28.25

$0.01 (0.04%)

$23

3 years 7 months 27 days ago
(11-Aug-2021)

9/12 (75%)

$0.67 (2.43%)

136

Hold

$28.25

$0.01 (0.04%)

$29

3 years 8 months 1 days ago
(06-Aug-2021)

1/8 (12.5%)

$0.88 (3.22%)

2

Hold

$23

3 years 10 months 20 days ago
(18-May-2021)

4/4 (100%)

$0.84 (3.79%)

41

Hold

$17

$-11.24 (-39.80%)

$17

4 years 5 months 23 days ago
(15-Oct-2020)

14/17 (82.35%)

$-0.7 (-3.95%)

99

Hold

$19

$-9.24 (-32.72%)

4 years 5 months 30 days ago
(08-Oct-2020)

1/2 (50%)

$0.69 (3.77%)

42

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is XENT (Intersect ENT) average time for price targets to be met?

On average it took 106.43 days on average for the stock forecasts to be realized with a an average price target met ratio 74.26

Which analyst has the current highest performing score on XENT (Intersect ENT) with a proven track record?

MATT O'BRIEN

Which analyst has the current lower performing score on XENT (Intersect ENT) with a proven track record?

ROBBIE MARCUS

Which analyst has the most public recommendations on XENT (Intersect ENT)?

Matt O'brien works at PIPER SANDLER and has 5 price targets and 7 ratings on XENT

Which analyst is the currently most bullish on XENT (Intersect ENT)?

Richard Newitter with highest potential upside - $0.01

Which analyst is the currently most reserved on XENT (Intersect ENT)?

Bob Hopkins with lowest potential downside - -$18.24

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?